GlassScriptPhysician profile
Suzanne Freeseman
NPI 1285750430
$14,992.11
in general payments reported to CMS, 2019-2025
17 companies · $812 in 2025
The $812 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12K · 2022: $670 · 2023: $609 · 2024: $781 · 2025: $812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,202.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $11,273.37 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $1,099.12 | 2021-2025 | Dupixent |
| Pfizer INC. | $408.12 | 2021-2025 | |
| Abbvie INC. | $377.49 | 2024-2025 | |
| Revance Therapeutics, INC. | $361.46 | 2024-2025 | Daxxify, Daxi |
| Sun Pharmaceutical Industries INC. | $357.55 | 2021-2025 | |
| Galderma Laboratories, L.P. | $262.78 | 2023-2025 | Nemluvio, Dysport |
| Genzyme Corporation | $230.87 | 2021-2023 | |
| Leo Pharma INC. | $203.98 | 2021-2022 | |
| Amgen INC. | $112.30 | 2021-2024 | Otezla |
| Novartis Pharmaceuticals Corporation | $78.89 | 2022-2024 | |
| Epi Health, LLC | $46.25 | 2021 | |
| Verrica Pharmaceuticals INC. | $40.31 | 2024-2025 | Ycanth |
| Almirall LLC | $39.25 | 2022 | |
| Boston Scientific Corporation | $39.09 | 2024 | Wavewriter Alpha Prime 16 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $35.59 | 2021-2022 | |
| Lilly USA, LLC | $25.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Freeseman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.